|
ZNF227 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.779790E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.50320000000304E-05 |
| Normal-vs-Stage2 |
8.799400E-03 |
| Normal-vs-Stage3 |
3.890300E-02 |
| Normal-vs-Stage4 |
4.819700E-02 |
| Stage1-vs-Stage2 |
8.722800E-01 |
| Stage1-vs-Stage3 |
5.963800E-01 |
| Stage1-vs-Stage4 |
5.884000E-01 |
| Stage2-vs-Stage3 |
7.896600E-01 |
| Stage2-vs-Stage4 |
5.406800E-01 |
| Stage3-vs-Stage4 |
4.433400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.375770E-04 |
| Normal-vs-AfricanAmerican |
2.755900E-02 |
| Normal-vs-Asian |
7.115500E-02 |
| Caucasian-vs-AfricanAmerican |
4.142000E-01 |
| Caucasian-vs-Asian |
9.461600E-01 |
| AfricanAmerican-vs-Asian |
7.527000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.86719999997853E-06 |
| Normal-vs-Female |
4.244400E-01 |
| Male-vs-Female |
3.477300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.174100E-02 |
| Normal-vs-Extreme_Weight |
4.12279999995047E-06 |
| Normal-vs-Obese |
4.797900E-02 |
| Normal-vs-Extreme_Obese |
1.501160E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.764000E-02 |
| Normal_Weight-vs-Obese |
7.043800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.563400E-01 |
| Extreme_Weight-vs-Obese |
1.477980E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.337800E-01 |
| Obese-vs-Extreme_Obese |
1.083430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.011000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.306400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.77437999999697E-05 |
| Normal-vs-Age(81-100Yrs) |
1.495770E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.610200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.756400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.351800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.301900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.608370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.869000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.20150000000464E-05 |
| Normal-VS-Type2 PRCC |
2.01599999999358E-05 |
| Normal-VS-KIRP CIMP |
7.272400E-01 |
| Normal-VS-Unclassified PRCC |
6.338100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.825970E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.500200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.851400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.564200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.429170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.005000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.229110E-04 |
| Normal-vs-N1 |
4.455200E-01 |
| Normal-vs-N2 |
4.347700E-02 |
| N0-vs-N1 |
7.832100E-02 |
| N0-vs-N2 |
9.770400E-01 |
| N1-vs-N2 |
4.438200E-01 |
|
|
